1. Researchers call out Gilead over diversity of remdesivir trials — Bristol-Myers commits $300M to combat racial disparities — Goldman predicts at least one coronavirus vaccine approval before the end of 2020 — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Congrats to SVNT execs

Discussion in 'Savient' started by Anonymous, Nov 6, 2013 at 9:13 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    nice pull on getting an extra 200K bonus on top of you salary to stick around and do nothing wating out bankruptcy. Sweet. I'll bet every fortune 500 company is hoping they can land you with that demonstrated ability to build shareholder value, and able to write safe harbor statements so you can say that there is 12 months of money left to fund operations and 9 weeks later file Ch. 11.

    Probably the best team and BOD ever in the history of biotech, and every employee and shareholder should send them even more money.

  2. Anonymous

    Anonymous Guest

    Sending them more money would be futile. They wouldn't know what to do with it.
  3. Anonymous

    Anonymous Guest

    They did a great job